Pyrazole-based lamellarin O analogues: synthesis, biological evaluation and structure-activity relationships.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
08 Mar 2023
08 Mar 2023
Historique:
received:
13
02
2023
accepted:
01
03
2023
entrez:
13
3
2023
pubmed:
14
3
2023
medline:
14
3
2023
Statut:
epublish
Résumé
A library of pyrazole-based lamellarin O analogues was synthesized from easily accessible 3(5)-aryl-1
Identifiants
pubmed: 36909769
doi: 10.1039/d3ra00972f
pii: d3ra00972f
pmc: PMC9999251
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7897-7912Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare.
Références
Mol Divers. 2020 Nov;24(4):1025-1042
pubmed: 31713185
Bioorg Med Chem. 2017 Dec 15;25(24):6563-6580
pubmed: 29133033
Molecules. 2021 Feb 24;26(5):
pubmed: 33668128
Acta Pharm Sin B. 2020 Mar;10(3):512-528
pubmed: 32140396
J Org Chem. 2021 Nov 5;86(21):14883-14902
pubmed: 34436897
Eur J Med Chem. 2018 Apr 25;150:908-919
pubmed: 29602037
Cold Spring Harb Protoc. 2016 Dec 1;2016(12):
pubmed: 27934681
Bioorg Med Chem Lett. 2007 Aug 15;17(16):4557-61
pubmed: 17574416
J Immunol Methods. 1991 Jun 3;139(2):271-9
pubmed: 1710634
RSC Adv. 2020 Nov 27;10(70):43168-43174
pubmed: 35514893
J Nat Prod. 2004 Jul;67(7):1168-71
pubmed: 15270574
Org Biomol Chem. 2012 Apr 7;10(13):2656-63
pubmed: 22361689
J Org Chem. 2020 Jul 2;85(13):8603-8617
pubmed: 32462869
Toxicology. 2021 Oct;462:152963
pubmed: 34560126
Apoptosis. 2010 Jul;15(7):769-81
pubmed: 20151196
Mol Divers. 2020 Nov;24(4):1235-1251
pubmed: 31420788
Beilstein J Org Chem. 2019 Mar 14;15:679-684
pubmed: 30931008
Mol Pharmacol. 2014 Aug;86(2):193-9
pubmed: 24890608
J Med Chem. 2020 Jun 25;63(12):6315-6386
pubmed: 32182061
Mar Drugs. 2014 Dec 18;12(12):6142-77
pubmed: 25528958
Mar Drugs. 2014 Jun 27;12(7):3818-37
pubmed: 24979269
Cell Mol Life Sci. 2017 Mar;74(5):777-801
pubmed: 27622244
Med Chem. 2019;15(7):743-754
pubmed: 30147012
Mar Drugs. 2015 Feb 19;13(3):1105-23
pubmed: 25706633
Alkaloids Chem Biol. 2020;83:1-112
pubmed: 32098648
J Org Chem. 2019 Sep 20;84(18):11596-11603
pubmed: 31433662
Molecules. 2022 Feb 21;27(4):
pubmed: 35209235
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Mar Drugs. 2014 Jan 27;12(2):779-98
pubmed: 24473175
Bioorg Med Chem. 2019 Jan 15;27(2):265-277
pubmed: 30553626
Bioorg Med Chem. 2021 Mar 15;34:116039
pubmed: 33556869
Nucl Med Biol. 2017 Jul;50:1-10
pubmed: 28364662
Eur J Med Chem. 2021 Mar 15;214:113226
pubmed: 33582387
Chem Asian J. 2012 Jun;7(7):1616-23
pubmed: 22473938
Nucl Med Biol. 2018 Mar;58:20-32
pubmed: 29309919
Bioorg Chem. 2022 Feb;119:105570
pubmed: 34953323
J Pharm Sci. 2003 Nov;92(11):2236-48
pubmed: 14603509
RSC Med Chem. 2019 Dec 16;11(1):18-29
pubmed: 33479602
Molecules. 2020 Mar 30;25(7):
pubmed: 32235463
Chem Rev. 2021 Feb 10;121(3):1670-1715
pubmed: 33382252
Chem Rev. 2008 Jan;108(1):264-87
pubmed: 18095718
J Am Chem Soc. 2013 Aug 28;135(34):12877-85
pubmed: 23909907
Curr Med Chem Anticancer Agents. 2004 Jul;4(4):363-78
pubmed: 15281908
J Med Chem. 2014 Oct 23;57(20):8238-48
pubmed: 25099658
J Nat Prod. 2019 Jul 26;82(7):2000-2008
pubmed: 31306000
Pharm Res. 2022 Feb;39(2):213-222
pubmed: 35112229
Molecules. 2021 Sep 15;26(18):
pubmed: 34577075
Clin Pharmacokinet. 2019 Oct;58(10):1265-1279
pubmed: 31089975
Molecules. 2022 Dec 09;27(24):
pubmed: 36557851
Molecules. 2022 Dec 07;27(24):
pubmed: 36557800
Molecules. 2021 Jun 22;26(13):
pubmed: 34206593
Bioorg Med Chem. 2017 Nov 15;25(22):6137-6148
pubmed: 28233677
Molecules. 2021 Nov 08;26(21):
pubmed: 34771163
Adv Drug Deliv Rev. 2016 Jun 1;101:34-41
pubmed: 27154268
Mol Cancer Ther. 2009 Dec;8(12):3307-17
pubmed: 19952118
J Nat Prod. 2015 Jun 26;78(6):1370-82
pubmed: 26039921
Bioorg Med Chem. 2018 Feb 1;26(3):703-711
pubmed: 29291938